Open AccessActive surveillance in metastatic pancreatic neuroendocrine tumors: A 20-year single-institutional experience
Author(s) -
Heli Gao,
Wenquan Wang,
Huaxiang Xu,
Chifei Wu,
Hao Li,
Quanxing Ni,
Lei Yu,
Liang Liu
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i17.3751
Subject(s) - medicine , neuroendocrine tumors , metastasis , gastroenterology , nomogram , oncology , primary tumor , multivariate analysis , stage (stratigraphy) , confidence interval , cancer , paleontology , biology
Pancreatic neuroendocrine tumors (PanNETs) are heterogeneous and indolent; systemic therapy is not essential for every patient with metastatic PanNET. The National Comprehensive Cancer Network guidelines state that delaying treatment is an option for PanNET with distant metastasis, if the patient has stable disease. However, specific factors that influence surveillance were not mentioned. In addition, data regarding the period of active surveillance in patients with metastatic PanNET are lacking.